XML 43 R23.htm IDEA: XBRL DOCUMENT v3.3.1.900
Subsequent Events
12 Months Ended
Dec. 26, 2015
Subsequent Events [Abstract]  
SUBSEQUENT EVENTS
SUBSEQUENT EVENTS
On January 6, 2016, the Company entered into a definitive agreement to acquire WRH, Inc. (WIL Research) for approximately $585.0 million in cash, subject to customary closing adjustments. WIL Research is a premier provider of safety assessment and contract development and manufacturing (CDMO) services to biopharmaceutical and agricultural and industrial chemical companies worldwide. Acquiring WIL Research will enhance the Company’s position as a leading global early-stage CRO by strengthening its ability to partner with global clients across the drug discovery and development continuum.
The transaction is expected to close early in the second quarter of 2016, subject to regulatory approvals and customary closing conditions. In connection with the plan to acquire WIL Research, the Company entered into a commitment letter, pursuant to which its existing credit facility will be expanded by up to $350.0 million. In the event the agreement is terminated under specified circumstances, the Company may be required to pay WIL Research a termination fee of $17.5 million. WIL Research is expected to be reported primarily as part of the Company’s DSA reportable segment.